I've been reading about AI's role in drug evaluations and how it might change the traditional FDA approval process, which I feel is often a major bottleneck in getting new drugs and treatments to patients. I'm curious if AI can really cut down the approval timeline, and if so, how would that work? I know clinical trials probably won't be completely bypassed—so where do you think the actual speed increases would come from? Also, could this extend to other tech innovations, like non-invasive brain-computer interfaces? If successful, we could see advancements in treatment during our lifetimes or potentially for future generations.
5 Answers
This aligns with what Demis Hassabis mentioned about more medicine being developed in-silico, which could really revolutionize healthcare in the coming years. Exciting times ahead!
Cheers to new AI formulations making a difference!
The article points out AI's potential in handling some administrative tasks, which sounds promising. But remember, a lot of the time spent in clinical trials goes into patient recruitment and monitoring. Even with AI advancements, we might still be decades away from fully skipping human drug trials.
Absolutely! Using AI to automate and accelerate various parts of the drug development pipeline is key. From idea generation to distributing treatments, there's a lot that can be optimized. It's not just about speeding things up, but making the whole process more efficient!
Yeah, that seems more plausible. It's not just about improving admin tasks either— the FDA is looking into rolling out AI across their reviews too!